Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study
Open Access
- 19 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (1) , 92-103
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation PatientsJACC, 2014
- Measuring Direct Thrombin Inhibitors With Routine and Dedicated Coagulation AssaysAmerican Journal of Clinical Pathology, 2012
- RivaroxabanClinical Pharmacokinetics, 2011
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjectsBritish Journal of Clinical Pharmacology, 2009
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976